| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/26/2011 | EP2019825B9 Inhibitors of human immunodeficiency virus replication |
| 01/26/2011 | EP1831173B1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 01/26/2011 | EP1633733B1 Cannabinoid derivatives, methods of making, and use thereof |
| 01/26/2011 | EP1572660B1 Isoquinolinone derivatives and their use as therapeutic agents |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | EP1480941B1 Urea derivatives as hiv aspartyl protease inhibitors |
| 01/26/2011 | CN101959879A 5-oxo-2, 3,4,5-tetrahydro-benzo[B]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[B]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2 |
| 01/26/2011 | CN101959876A 2-aminoquinolines |
| 01/26/2011 | CN101959864A 2-aminoquinoline derivatives |
| 01/26/2011 | CN101959855A Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 01/26/2011 | CN101959557A 2-aminoquinolines as 5-HT5A receptor antagonists |
| 01/26/2011 | CN101955477A 2-cyclopropyl-4-substituted thiophenyl quinoline compounds as well as intermediate, preparation method and application thereof |
| 01/26/2011 | CN101282967B Total synthesis of pladienolide b and pladienolide D |
| 01/25/2011 | US7875728 Hydrazonopyrazole derivatives and their use as therapeutics |
| 01/25/2011 | US7875621 Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors |
| 01/25/2011 | US7875619 Hetero substituted sodium channel blockers |
| 01/25/2011 | US7875607 7,8-bicycloakyl-chroman derivatives |
| 01/25/2011 | US7875600 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide |
| 01/25/2011 | CA2472776C Process for the manufacture of hmg-coa reductase inhibitors |
| 01/25/2011 | CA2460180C Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives |
| 01/25/2011 | CA2410345C Substituted pyridine herbicides |
| 01/25/2011 | CA2388468C Mediators of hedgehog signalling pathways, compositions and uses related thereto |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/20/2011 | WO2011007722A1 3-substituted-2-furancarboxylic acid hydrazide derivative and pharmaceutically acceptable salt thereof |
| 01/20/2011 | WO2011006935A2 Tetrazole derivatives |
| 01/20/2011 | WO2011006903A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | WO2011006803A1 3-0x0-2, 3, -dihydro-lh-isoindole-4-carboxamides with selective parp-1 inhibition |
| 01/20/2011 | WO2011006794A1 3-oxo-2, 3-dihydro-lh-isoindole-4-carboxamides as parp inhibitors |
| 01/20/2011 | WO2011006610A1 Non-polar and polar leaving groups |
| 01/20/2011 | WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 01/20/2011 | WO2011006208A1 Anti -influenza agents |
| 01/20/2011 | WO2010138484A3 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
| 01/20/2011 | US20110015400 Process for the preparation of tryptase inhibitors |
| 01/20/2011 | US20110015243 Co-solvent compositions and methods for improved delivery of dantrolene theraputic agents |
| 01/20/2011 | US20110015234 Indazole derivatives |
| 01/20/2011 | US20110015232 Pyrrolydine Derivatives as IAP Inhibitors |
| 01/20/2011 | US20110015203 Viral Polymerase Inhibitors |
| 01/20/2011 | US20110015185 Benzofuran Compounds |
| 01/20/2011 | US20110015182 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
| 01/20/2011 | US20110015180 Chemokine receptor antagonists |
| 01/20/2011 | US20110015174 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 01/20/2011 | US20110015152 Diarylmethyl and related compounds |
| 01/20/2011 | CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases |
| 01/20/2011 | CA2768081A1 Anti-influenza agents |
| 01/20/2011 | CA2767470A1 Non-polar and polar leaving groups |
| 01/20/2011 | CA2766874A1 Tetrazole derivatives |
| 01/19/2011 | EP2275413A1 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders. |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP2275105A1 Heterocyclic derivatives as opioid receptor modulators |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2274297A1 Pyrrolidinone glucokinase activators |
| 01/19/2011 | EP2274296A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/19/2011 | EP2274283A1 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 01/19/2011 | EP2273992A1 Quenolines and related analogs as sirtuin modulators |
| 01/19/2011 | EP2035375B1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 01/19/2011 | EP1534255B1 Processes for preparing 1,3-dioxolane nucleosides |
| 01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2011 | EP1330442B1 Phthalazinone derivatives |
| 01/19/2011 | EP1067123B1 Nitrogenous heterocyclic compounds |
| 01/19/2011 | CN101952279A Azolylmethyloxiranes, use thereof and agents containing the same |
| 01/19/2011 | CN101952259A Benzodiazepine compound and pharmaceutical composition |
| 01/19/2011 | CN101952258A Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/19/2011 | CN101952254A Isoquinoline modulators of ATP-binding cassette transporters |
| 01/19/2011 | CN101951771A Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
| 01/19/2011 | CN101948453A Novel NEO-clerodane typed diterpene compound and application thereof |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/19/2011 | CN101072773B Pyrrole derivatives having CRTH2 receptor antagonist activity |
| 01/19/2011 | CN101052638B 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 01/19/2011 | CN101003499B Novel color former and recording material |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872126 Tetrahydroquinoline derivatives and a process for preparing the same |
| 01/18/2011 | US7872039 3-aminoindazoles |
| 01/18/2011 | US7872030 Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 01/18/2011 | US7872024 Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions |
| 01/18/2011 | US7872021 Liver X receptors (LXR) modulators such as 1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-4-methoxy-N-(2-phenyl ethyl)-2,3-dihydro-1H-)indole-2-carboxamide, used for the treatment of atherosclerosis, dyslipidemia, obesity, diabetes, hypercholesterolemia, neurodegenerative diseases and inflammatory diseases |
| 01/18/2011 | US7872011 Inhibition of phosphoinositide 3-kinase β |
| 01/18/2011 | CA2573219C Hepatitis c inhibitor dipeptide analogs |
| 01/18/2011 | CA2568590C Propane-1,3-dione derivative or salt thereof useful as gnrh receptor antagonist |
| 01/18/2011 | CA2511301C Acylsufonamide compounds as inhibitors of rna-dependent rna viral polymerase |
| 01/18/2011 | CA2491895C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/18/2011 | CA2384134C N-arylmethylthioanilide compounds useful for the inhibition of the replication of hiv |
| 01/13/2011 | WO2011005674A1 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | WO2011005660A1 Tofa analogs useful in treating dermatological disorders or conditions |
| 01/13/2011 | WO2011004639A1 Organic electroluminescent element, novel compound, lighting device and display device |
| 01/13/2011 | WO2011004016A1 Pyridine derivatives with umami flavour |
| 01/13/2011 | WO2011003992A1 A crystalline form of posaconazole |
| 01/13/2011 | WO2011003528A2 Substituted phenyl(oxy/thio)alkanol derivatives |
| 01/13/2011 | WO2010046780A3 Anti viral compounds |
| 01/13/2011 | WO2010012442A8 Insecticidal benzenedicarboxamide derivative |
| 01/13/2011 | US20110009626 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 01/13/2011 | US20110009624 Benzimidazole compounds having gastric acid secretion inhibitory action |
| 01/13/2011 | US20110009620 4-Amino-5-cyanopyrimidine derivatives |
| 01/13/2011 | US20110009459 Epothilone derivatives |
| 01/13/2011 | US20110009455 5-Oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-Dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of Diabetes Typ 1 and 2 |
| 01/13/2011 | US20110009454 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
| 01/13/2011 | US20110009440 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 01/13/2011 | US20110009428 Novel androgens |